-
Filgotinib, sold
under the
brand name Jyseleca, is a
medication used for the
treatment of
rheumatoid arthritis (RA). It was
developed by the Belgian-Dutch...
- to
amend certain terms around the
development and
commercialization of
filgotinib. In June 2022, the
business announced it
would acquire CellPoint for €125...
- and vitiligo.
Examples are tofacitinib, baricitinib,
upadacitinib and
filgotinib. In 2014
researchers discovered that oral JAK inhibitors, when administered...
- T-cell JAK-STAT
signaling is
inhibited by the
medications tofacitinib,
filgotinib and
upadacitinib which are used in the
treatment of
ulcerative colitis...
- JAK1
Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2 Atiprimod...
-
pharmaceutical drugs that
contain a
triazolopyridine ring
system include filgotinib, tucatinib, and enarodustat. In addition, the
reagents used in organic...
-
Agency (EMA)
recommends that the J****
kinase inhibitors abrocitinib,
filgotinib, baricitinib, upadacitinib, and
tofacitinib should be used in the following...
- JAK1
Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2 Atiprimod...
- JAK1
Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2 Atiprimod...
-
numbers of T-lymphocytes etc.
unknown etanercept decoy TNF
receptor bDMARD filgotinib J****
kinase (JAK)
inhibitor tsDMARD golimumab TNF
inhibitor bDMARD gold...
